Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NanoImmunoRT

Financiado

Synergizing enhanced radiotherapy with tumor-associated macrophages-targeted imm...

Synergizing enhanced radiotherapy with tumor-associated macrophages-targeted immunotherapy in glioblastoma with multimodal therapeutic nanoparticles In glioblastoma (GBM), intrinsic and environmental factors are limiting the efficacy of radiation therapy (RT) and immunotherapy. These factors include intrinsic cancer cells resistance, hypoxia, and the presence of immunosuppress... ver más

31/12/2025

CNRS

125K€

Presupuesto del proyecto: 125K€

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-11

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CNRS

124.96K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

OncoNanoR Engineering the immunosuppressive microenvironment in mesoth... 216K€ Cerrado

PID2020-119368RB-I00 NANO-INMUNOTERAPIAS COMBINADAS BASADAS EN SIRNA APLICADAS... 295K€ Cerrado

PCIN-2017-129 NANO-INMUNOTERAPIA: TARGETING INTRACELULAR DE CELULAS TUMORA... 150K€ Cerrado

RADIANCE Nanoscintillators to potentiate brain cancer radiotherapy:... 2M€ Cerrado

MAGNOSTICS Biomimetic MAGnetic nanoparticles with homotypic targeting f... 173K€ Cerrado

PCI2019-103725 PHOTOACTIVABLE NANOPARTICLES TO IMMUNOSTIMULATE THE TUMOUR M... 145K€ Cerrado

Duración del proyecto: 31 meses Fecha Inicio: 2023-05-11
Fecha Fin: 2025-12-31

Líder del proyecto

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 125K€

Descripción del proyecto In glioblastoma (GBM), intrinsic and environmental factors are limiting the efficacy of radiation therapy (RT) and immunotherapy. These factors include intrinsic cancer cells resistance, hypoxia, and the presence of immunosuppressive cells such as tumor–associated macrophages (TAMs). Considering these current limitations for RT efficacy and the specific deleterious role of TAMs in GBM, I designed an original therapeutic strategy combining enhanced RT and TAMs reprogramming with toll-like receptors (TLRs) agonists to synergize direct cytotoxicity to tumors cells at low radiation doses with immunotherapy for both local and recurrent tumor rejection. For this, I will use relevant radio-sensitizing moieties for GBM: high Z atoms which can efficiently absorb, scatter, and emit radiation energy and catalase, an enzyme capable of converting H2O2 to oxygen in the tumor microenvironment (TME). It will be simultaneously applied with the combination of the TLRs agonists poly(I:C) and resiquimod, which will be used to re-educate TAMs and prepare the TME to a strong anti-tumoral immune response. The selected molecules will be incorporated in a new Multimodal Therapeutic NanoParticle (MTNP), based on a nanosized zeolite structure, allowing to combine the two approaches in a unique particle. The MTNPs will be tested in vitro and in vivo in murine model of GBM and patient-derived samples, to verify their effectiveness in enhancing RT and reeducating TAMs, and their effect on tumor growth. The present multidisciplinary research program aims at supporting greater progress in the treatment of brain tumors and ultimately leading to improved outcomes for cancer patients.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores